U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2006
178
Name Type Language
PANITUMUMAB
EMA EPAR   INN   MART.   MI   USAN   VANDF   WHO-DD  
INN   USAN  
Official Name English
PANITUMUMAB [PURPLE BOOK CDER]
Common Name English
panitumumab [INN]
Common Name English
PANITUMUMAB [MART.]
Common Name English
PANITUMUMAB [VANDF]
Common Name English
PANITUMUMAB [JAN]
Common Name English
PANITUMUMAB [EMA EPAR]
Common Name English
E7.6.3
Code English
Panitumumab [WHO-DD]
Common Name English
PANITUMUMAB [USAN]
Common Name English
PANITUMUMAB [MI]
Common Name English
IMMUNOGLOBULIN, HUMAN (ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) MONOCLONAL ANTIBODY (ABX-EGF)
Common Name English
ABENIX
Brand Name English
ABX-EGF
Code English
IMMUNOGLOBULIN, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN MONOCLONAL ABX-EGF HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ABX-EGF LIGHT CHAIN, DIMER
Common Name English
Classification Tree Code System Code
LIVERTOX NBK548182
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
EMA ASSESSMENT REPORTS VECTIBIX (AUTHORIZED: COLORECTAL NEOPLASMS)
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
NCI_THESAURUS C129822
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
NCI_THESAURUS C1742
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
NCI_THESAURUS C133878
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
NDF-RT N0000175664
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
WHO-VATC QL01XC08
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
WHO-ATC L01XC08
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
Code System Code Type Description
RXCUI
263034
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
PRIMARY RxNorm
USAN
PP-83
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
PRIMARY
IUPHAR
6883
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
PRIMARY
MERCK INDEX
m8382
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
PRIMARY Merck Index
INN
8499
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
PRIMARY
CAS
339177-26-3
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
PRIMARY
NCI_THESAURUS
C1857
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
PRIMARY
ChEMBL
CHEMBL1201827
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
PRIMARY
SMS_ID
100000089383
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
PRIMARY
FDA UNII
6A901E312A
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
PRIMARY
DAILYMED
6A901E312A
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
PRIMARY
DRUG CENTRAL
4955
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
PRIMARY
DRUG BANK
DB01269
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
PRIMARY
WIKIPEDIA
PANITUMUMAB
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
PRIMARY
EVMPD
SUB25390
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
PRIMARY
MESH
C500592
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
PRIMARY
LACTMED
Panitumumab
Created by admin on Sat Dec 16 16:56:21 GMT 2023 , Edited by admin on Sat Dec 16 16:56:21 GMT 2023
PRIMARY
ACTIVE MOIETY
PANITUMUMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966